These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6807704)

  • 41. Clinical investigation of agents with prophylactic anti-allergic effects in bronchial asthma.
    Craps L; Greenwood C; Radielovic P
    Clin Allergy; 1978 Jul; 8(4):373-82. PubMed ID: 101313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Controversies in therapy of bronchial asthma].
    von Wichert P; Feddersen CO
    Internist (Berl); 1994 Apr; 35(4):376-84. PubMed ID: 8200762
    [No Abstract]   [Full Text] [Related]  

  • 43. New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):105-12. PubMed ID: 6104451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bronchial asthma. Advances].
    Girón Caro F
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():17-24. PubMed ID: 6140890
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term study of the protective effect of ketotifen in children with allergic bronchial asthma. The value of a provocation test in assessment of treatment.
    Klein G; Urbanek R; Matthys H
    Respiration; 1981; 41(2):128-32. PubMed ID: 6114524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The protective effect of inhaled terbutaline, sodium cromoglycate and budesonide on exercise-induced asthma in children.
    Pichaipat V; Tongpenyai Y; Nerntong T; Sriprapachiranont C
    J Med Assoc Thai; 1995 Oct; 78(10):505-8. PubMed ID: 8576655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ketotifen in childhood allergic disease.
    Warner JO; Goldsworthy SJ
    Clin Allergy; 1982 Oct; 12 Suppl():21-7. PubMed ID: 6814787
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinico-experimental possibilities in asthma].
    Debelic M
    Clin Ter; 1984 Feb; 108(4):273-82. PubMed ID: 6232063
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical role of antiallergic drugs in the treatment for bronchial asthma].
    Nakashima A
    Kokyu To Junkan; 1991 Sep; 39(9):873-8. PubMed ID: 1749864
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Jul; 35(5):413-9. PubMed ID: 6108726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contemporary problems of epidemiology and treatment of respiratory allergies and bronchial asthma.
    Zavázal V
    Czech Med; 1980; 3(4):255-62. PubMed ID: 6785056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ketotifene: experimental and clinical data].
    Craps L
    Schweiz Med Wochenschr; 1980 Feb; 110(6):187-91. PubMed ID: 6769157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of immediate- and late-response inhibition of a new beta-agonist, KWD 2131, compared with terbutaline and DSCG.
    Hegardt B; Pauwels R; Van der Straeten M
    Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():283-5. PubMed ID: 6796524
    [No Abstract]   [Full Text] [Related]  

  • 55. [Suppression of non-specific bronchial hyperreactivity by DSCG (Disodium cromoglycate) and ipratropium bromide (author's transl)].
    Götz M; Popow C
    Wien Klin Wochenschr; 1980 Sep; 92(18):638-41. PubMed ID: 6451084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Protective effect of Sm 857 (Doqualast) in allergic bronchial asthma].
    Wiessmann KJ; Ollrogge M; Rinast E; Schultek T; Wood WG
    Prax Klin Pneumol; 1986 Nov; 40(11):442-7. PubMed ID: 3543921
    [No Abstract]   [Full Text] [Related]  

  • 57. [Is the indication for DSCG limited to pure allergic asthma].
    Gillard C; Dierck JP; Gossart R
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):355-61. PubMed ID: 4219101
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical trial of sodium cromoglycate in allergic and non-allergic asthma and chronic bronchitis].
    Perrin-Fayolle M; Kofman J; Biot N; Cassan G; Meyrand P
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):362-83. PubMed ID: 4219102
    [No Abstract]   [Full Text] [Related]  

  • 59. [Results and prospects of using becotid in bronchial asthma and other allergic diseases].
    Il'kovich MM
    Sov Med; 1980; (8):74-7. PubMed ID: 6999633
    [No Abstract]   [Full Text] [Related]  

  • 60. [Dosage of DNCG (Intal, Aarane)].
    Darlath W; Voss HW
    Pneumologie; 1998 Dec; 52(12):730-1. PubMed ID: 10028845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.